TOKYO, September 28, 2012 /PRNewswire/ --
Marks first approval for glycopyrronium bromide in COPD, with approval also expected in the EU in 2012
Approval triggers $2.5m milestone payment to Sosei
Seebri® Inhalation Capsules 50 mcg approved as maintenance COPD...